
  
    
      
        Introduction_NNP
        Chronic_NNP inhalation_NN of_IN tobacco_NN smoke_NN causes_NNS progressive_JJ lung_NN destruction_NN in_IN susceptible_JJ
        individuals_NNS ,_, resulting_VBG in_IN chronic_JJ obstructive_JJ pulmonary_JJ disease_NN (_( COPD_NNP )_) and_CC emphysema_NN ,_, two_CD
        well-described_JJ clinical_JJ syndromes_NNS with_IN poorly_RB understood_VBN pathogenesis_NNS [_NN 1_CD ,_, 2_CD ,_, 3_CD ]_NN ._. A_DT role_NN for_IN T_NN
        helper_NN cells_NNS in_IN the_DT pathogenesis_NNS of_IN obstructive_JJ lung_NN disease_NN has_VBZ been_VBN established_VBN with_IN
        asthma_NN ,_, where_WRB T_NN helper_NN 2_CD (_( Th_NNP 2_LS )_) cells_NNS are_VBP strongly_RB linked_VBN to_TO both_DT human_JJ and_CC experimental_JJ
        disease_NN [_NN 4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ]_NN ._. A_DT potential_JJ role_NN for_IN T_NN cells_NNS in_IN COPD_NNP has_VBZ also_RB been_VBN suggested_VBN in_IN several_JJ
        recent_JJ studies_NNS that_WDT show_NN CD_NNP 8_CD
        +_NN T_NN cells_NNS are_VBP increased_VBN in_IN the_DT lungs_NNS of_IN people_NNS who_WP smoke_VBP [_NN 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD ]_NN ._. T_NN
        cells_NNS cause_VBP tissue_NN injury_NN through_IN their_PRP$ secreted_JJ products_NNS such_JJ as_IN cytokines_NNS ;_: in_IN mice_NNS ,_,
        overexpression_NN of_IN interleukin_NN (_( IL_NNP )_) -_: 13_CD ,_, a_DT T_NN cell_NN cytokine_NN that_WDT is_VBZ strongly_RB implicated_VBN in_IN the_DT
        pathogenesis_NNS of_IN experimental_JJ asthma_NN ,_, resulted_VBD in_IN increased_VBN production_NN of_IN proteases_NNS and_CC
        enlargement_NN of_IN airspaces_NNS reminiscent_NN of_IN emphysema_NN [_NN 12_CD ]_NN ._. Further_RB ,_, airway_NN limitation_NN ,_, another_DT
        characteristic_NN of_IN human_JJ asthma_NN ,_, is_VBZ clinically_RB linked_VBN to_TO an_DT accelerated_VBN rate_NN of_IN loss_NN of_IN lung_NN
        function_NN in_IN smoker_NN individuals_NNS [_NN 13_CD ]_NN ._. It_PRP has_VBZ been_VBN suggested_VBN ,_, therefore_RB ,_, that_DT asthma_NN and_CC COPD_NNP
        may_MD involve_VB the_DT same_JJ type_NN of_IN recruited_VBN inflammatory_JJ cells_NNS ,_, differing_VBG only_RB in_IN their_PRP$ location_NN
        within_IN the_DT lung_NN [_NN 14_CD ]_NN ._.
        Chemokines_NNP ,_, their_PRP$ receptors_NNS ,_, and_CC cell_NN adhesion_NN molecules_NNS regulate_VB migration_NN of_IN immune_JJ
        cells_NNS into_IN inflamed_JJ tissue_NN [_NN 15_CD ,_, 16_CD ,_, 17_CD ,_, 18_CD ]_NN ._. T_NN helper_NN 1_CD (_( Th_NNP 1_LS )_) cells_NNS have_VBP been_VBN shown_VBN to_TO secrete_NN
        interleukin_NN 2_CD and_CC interferon_NN gamma_NN (_( IFN-γ_NNP )_) ,_, and_CC express_VB a_DT distinct_JJ repertoire_NN of_IN chemokine_NN
        receptors_NNS such_JJ as_IN CCR_NNP 5_CD and_CC CXCR_NNP 3_CD [_NN 19_CD ,_, 20_CD ,_, 21_CD ]_NN ._. In_IN contrast_NN ,_, Th_NNP 2_CD cells_NNS that_WDT are_VBP biased_VBN to_TO
        produce_VB IL-_NNP 4_CD and_CC IL-_NNP 5_CD express_VB mainly_RB CCR_NNP 4_CD and_CC CCR_NNP 3_CD [_NN 22_CD ,_, 23_CD ,_, 24_CD ,_, 25_CD ]_NN ._. Immunofluorescent_NNP
        analysis_NN of_IN airway_NN mucosal_NN biopsies_NNS in_IN patients_NNS with_IN asthma_NN showed_VBD that_IN most_JJS T_NN cells_NNS
        co-express_JJ IL-_NNP 4_CD and_CC CCR_NNP 4_CD ,_, but_CC ,_, in_IN contrast_NN ,_, T_NN cells_NNS in_IN airways_NNS of_IN patients_NNS with_IN COPD_NNP and_CC
        pulmonary_JJ sarcoidosis_NNS produce_VBP IFN-γ_NNP and_CC express_VB high_JJ levels_NNS of_IN CXCR_NNP 3_CD ,_, while_IN lacking_VBG CCR_NNP 4_CD
        expression_NN [_NN 26_CD ]_NN ._. In_IN addition_NN to_TO T_NN cells_NNS ,_, a_DT wide_JJ variety_NN of_IN other_JJ inflammatory_JJ cells_NNS have_VBP
        been_VBN shown_VBN to_TO express_VB distinct_JJ chemokine_NN receptors_NNS that_WDT are_VBP critical_JJ for_IN their_PRP$ homing_VBG ,_,
        suggesting_VBG a_DT universal_JJ mechanism_NN for_IN regulating_VBG immune_JJ responses_NNS ._. Interferon-inducible_NNP
        protein_NN 10_CD (_( IP-_NNP 10_CD )_) ,_, monokine_NN induced_VBN by_IN interferon_NN gamma_NN (_( MIG_NNP )_) ,_, and_CC interferon-inducible_JJ T_NN
        cell_NN alpha_NN chemoattractant_NN (_( I-TAC_NNP )_) are_VBP three_CD known_VBN ligands_NNS for_IN CXCR_NNP 3_CD produced_VBN by_IN normal_JJ and_CC
        injured_VBN epithelial_NN cells_NNS and_CC T_NN cells_NNS that_WDT are_VBP required_VBN for_IN homing_VBG of_IN Th_NNP 1_CD cells_NNS [_NN 27_CD ,_, 28_CD ,_, 29_CD ]_NN ._.
        In_IN addition_NN to_TO regulation_NN of_IN chemotaxis_NNS and_CC homing_VBG ,_, other_JJ functions_NNS have_VBP been_VBN ascribed_VBN to_TO
        chemokines_NNS ,_, including_VBG modulation_NN of_IN T_NN cell_NN fate_NN by_IN direct_JJ effects_NNS on_IN differentiating_VBG T_NN
        cells_NNS ,_, and_CC regulation_NN of_IN proteolysis_NNS in_IN blood_NN monocytes_NNS [_NN 19_CD ,_, 30_CD ]_NN ._.
        In_IN this_DT study_NN we_PRP determined_VBD the_DT dominant_JJ T_NN helper_NN phenotype_NN in_IN lung_NN samples_NNS from_IN
        ex-smoker_JJ individuals_NNS with_IN moderate_JJ to_TO severe_JJ COPD_NNP and_CC emphysema_NN and_CC control_NN individuals_NNS
        with_IN no_DT evidence_NN of_IN smoking-related_JJ lung_NN disease_NN ._. Analysis_NNP of_IN chemokine_NN receptor_NN expression_NN
        on_IN isolated_VBN peripheral_JJ lung_NN lymphocytes_NNS from_IN ex-smokers_JJ with_IN COPD_NNP /_NN emphysema_NN indicated_VBD that_IN
        both_DT CD_NNP 4_CD and_CC CD_NNP 8_CD T_NN helper_NN cells_NNS are_VBP strongly_RB polarized_VBN to_TO the_DT Th_NNP 1_CD phenotype_NN compared_VBN to_TO T_NN
        cells_NNS isolated_VBN from_IN lung_NN tissue_NN of_IN normal_JJ individuals_NNS or_CC individuals_NNS with_IN
        non-smoking-related_JJ obstructive_JJ lung_NN disease_NN ._. The_DT same_JJ cells_NNS spontaneously_RB secreted_JJ more_JJR
        IFN-γ_NNP and_CC CXCR_NNP 3_CD receptor_NN ligands_NNS MIG_NNP and_CC IP-_NNP 10_CD in_IN the_DT COPD_NNP and_CC emphysema_NN group_NN than_IN in_IN the_DT
        group_NN without_IN emphysema_NN ._. Further_RB ,_, IP-_NNP 10_CD and_CC MIG_NNP ,_, but_CC not_RB IFN-γ_NNP ,_, upregulated_JJ macrophage_NN
        metalloelastase_NN (_( matrix_NN metalloproteinase_NN [_NN MMP_NNP ]_NN -_: 12_CD )_) from_IN isolated_VBN lung_NN macrophages_NNS ._.
        Together_RB ,_, our_PRP$ findings_NNS reveal_VBP the_DT strong_JJ association_NN between_IN COPD_NNP /_NN emphysema-_NN and_CC Th_NNP 1_CD -_: driven_VBN
        adaptive_JJ immunity_NN ,_, suggesting_VBG a_DT link_NN to_TO lung_NN destruction_NN mediated_JJ by_IN IFN-γ_NNP ,_, MIG_NNP ,_, and_CC
        IP-_NNP 10_CD ._.
      
      
        Methods_NNP
        
          Participants_NNS
          Twenty-eight_NNP non-atopic_JJ ex-smoker_JJ individuals_NNS (_( see_VB Table_NNP 1_LS )_) undergoing_VBG medically_RB
          necessary_JJ lung_NN resection_NN were_VBD serially_RB entered_VBN into_IN the_DT study_NN :_: ten_CD individuals_NNS with_IN no_DT
          COPD_NNP and_CC no_DT evidence_NN of_IN emphysema_NN (_( control_NN group_NN )_) and_CC eighteen_NN individuals_NNS (_( diseased_JJ
          group_NN )_) with_IN moderate_JJ to_TO severe_JJ COPD_NNP and_CC evidence_NN of_IN emphysema_NN as_IN determined_VBN by_IN pulmonary_JJ
          function_NN tests_NNS ,_, high-resolution_JJ computed_JJ tomography_NN (_( CT_NNP )_) ,_, or_CC conventional_JJ CT_NNP scan_VB ._. All_DT
          participants_NNS were_VBD ex-smokers_JJ who_WP had_VBD quit_VBN smoking_VBG for_IN a_DT mean_NN (_( SD_NNP )_) of_IN 7_CD (_( 2_LS )_) y_NN and_CC 4_CD (_( 2_LS )_) y_NN
          in_IN COPD_NNP /_NN emphysema_NN and_CC control_NN groups_NNS ,_, respectively_RB ._. COPD_NNP was_VBD diagnosed_VBN according_VBG to_TO the_DT
          criteria_NNS recommended_VBN by_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP /_NN World_NNP Health_NNP Organization_NNP
          workshop_NN summary_NN [_NN 31_CD ]_NN ._. Participants_NNS in_IN the_DT control_NN and_CC COPD_NNP /_NN emphysema_NN groups_NNS had_VBD similar_JJ
          (_( mean_VB [_NN SD_NNP ]_NN of_IN 54_CD [_NN 6_CD ]_NN and_CC 45_CD [_NN 5_CD ]_NN ,_, respectively_RB )_) “ pack-year_JJ” smoking_NN histories_NNS ,_, where_WRB
          smoking_NN one_CD pack_NN of_IN cigarettes_NNS per_IN day_NN each_DT year_NN is_VBZ defined_VBN as_IN one_CD pack-year_JJ ._.
          All_DT participants_NNS were_VBD recruited_VBN from_IN the_DT surgical_JJ clinic_NN at_IN the_DT Michael_NNP E_NNP ._. DeBakey_NNP
          Veterans_NNP Affairs_NNPS Medical_NNP Center_NNP and_CC the_DT Methodist_NNP Hospital_NNP ,_, and_CC were_VBD undergoing_VBG lung_NN
          resection_NN for_IN diagnostic_JJ or_CC therapeutic_JJ purposes_NNS (_( Table_NNP 1_LS )_) ._. Study_NN protocols_NNS were_VBD approved_VBN
          by_IN the_DT institutional_JJ review_NN board_NN for_IN human_JJ studies_NNS ,_, and_CC informed_VBD consent_NN was_VBD obtained_VBN
          from_IN all_DT participants_NNS ._. Participants_NNS had_VBD no_DT history_NN of_IN allergy_NN or_CC asthma_NN and_CC had_VBD not_RB
          received_VBN oral_JJ /_NN systemic_JJ corticosteroids_NNS during_IN the_DT last_JJ 6_CD mo_NN ._. At_IN the_DT time_NN of_IN study_NN ,_, all_DT
          participants_NNS had_VBD been_VBN free_JJ of_IN acute_JJ symptoms_NNS suggestive_JJ of_IN upper_JJ or_CC lower_JJR respiratory_JJ
          tract_NN infection_NN for_IN the_DT 6_CD wk_NN preceding_VBG the_DT study_NN ._.
        
        
          CT-Based_NNP Evaluation_NNP for_IN Emphysema_NNP
          High-resolution_NNP CT_NNP (_( two_CD in_IN emphysema_NN group_NN and_CC two_CD in_IN control_NN group_NN )_) or_CC conventional_JJ
          CT_NNP analysis_NN was_VBD used_VBN to_TO detect_VB emphysema_NN ,_, characterized_VBN by_IN the_DT presence_NN of_IN areas_NNS of_IN low_JJ
          attenuation_NN contrasted_VBN with_IN surrounding_VBG normal_JJ lung_NN parenchyma_NN [_NN 32_CD ,_, 33_CD ]_NN ._. CT_NNP scans_NNS were_VBD
          used_VBN by_IN a_DT radiologist_NN to_TO separate_JJ participants_NNS on_IN the_DT basis_NN of_IN the_DT presence_NN or_CC the_DT
          absence_NN of_IN any_DT objective_NN evidence_NN for_IN centrilobular_NN ,_, panacinar_NN ,_, or_CC paraseptal_NN emphysema_NN
          with_IN a_DT detection_NN limit_NN of_IN greater_JJR than_IN 3_CD -_: mm_NN low_JJ attenuation_NN density_NN [_NN 34_CD ]_NN ._.
        
        
          Isolation_NNP of_IN Lung_NNP Lymphocytes_NNP
          Lung_NNP lymphocytes_NNS were_VBD isolated_VBN by_IN modifying_VBG established_VBN protocols_NNS ,_, using_VBG a_DT combination_NN
          of_IN mechanical_JJ fragmentation_NN ,_, enzyme_NN digestion_NN ,_, and_CC centrifugation_NN procedures_NNS described_VBD
          previously_RB [_NN 35_CD ,_, 36_CD ,_, 37_CD ]_NN ._. Viable_NNP lymphocytes_NNS were_VBD separated_JJ from_IN whole_JJ lung_NN inflammatory_JJ
          cells_NNS (_( macrophages_NNS ,_, eosinophils_NNS ,_, and_CC neutrophils_NNS )_) using_VBG an_DT immunomagnetic_JJ positive_JJ
          separation_NN technique_NN (_( autoMACS_NN ,_, Miltenyi_NNP Biotec_NNP ,_, Auburn_NNP ,_, California_NNP ,_, United_NNP States_NNPS )_) ._.
          Briefly_NNP ,_, lung_NN leukocytes_NNS were_VBD labeled_VBN with_IN paramagnetic_JJ bead-conjugated_JJ anti-_NN CD_NNP 3_CD ,_, -_: CD_NNP 19_CD ,_,
          and_CC -_: CD_NNP 56_CD to_TO positively_RB select_VB T_NN ,_, B_NNP ,_, and_CC NK_NNP cells_NNS ,_, according_VBG to_TO the_DT manufacturer_NN 's_POS
          instructions_NNS ._. Each_DT of_IN the_DT harvested_VBN cell_NN populations_NNS was_VBD used_VBN directly_RB for_IN in_IN vitro_NN
          assays_NNS or_CC was_VBD cryopreserved_JJ in_IN aliquots_NNS of_IN 1_CD ×_NN 10_CD
          7_CD cells_NNS for_IN future_JJ analysis_NN ._.
        
        
          Antibodies_NNP
          The_DT following_VBG monoclonal_NN antibodies_NNS were_VBD purchased_VBN from_IN BD_NNP Biosciences_NNP Pharmingen_NNP (_( San_NNP
          Diego_NNP ,_, California_NNP ,_, United_NNP States_NNPS )_) :_: FITC-_NNP ,_, Cy_NNP 5_CD -_: ,_, and_CC PE-conjugated_NNP anti-_NN CD_NNP 4_CD ,_, -_: CD_NNP 8_CD ,_, -_: CD_NNP 3_CD ,_,
          -_: CD_NNP 14_CD ,_, -_: CD_NNP 69_CD ,_, -_: CXCR_NNP 3_CD ,_, -_: CCR_NNP 3_CD ,_, -_: CCR_NNP 4_CD ,_, and_CC -_: CCR_NNP 5_CD ._. For_IN enzyme-linked_JJ immunosorbent_NN assay_NN
          studies_NNS ,_, anti-human_JJ antibodies_NNS to_TO IFN-γ_NNP ,_, IL-_NNP 4_CD ,_, IP-_NNP 10_CD ,_, MIG_NNP ,_, I-TAC_NNP ,_, and_CC the_DT appropriate_JJ
          secondary_JJ reagents_NNS were_VBD purchased_VBN from_IN R_NN &_CC D_NNP Systems_NNPS (_( Minneapolis_NNP ,_, Minnesota_NNP ,_, United_NNP
          States_NNPS )_) ._.
        
        
          Quantification_NNP of_IN Polarized_NNP Peripheral_NNP Blood_NNP and_CC Lung_NNP Lymphocyte_NNP Subsets_NNP
          Phenotypic_NNP characterization_NN of_IN T_NN cells_NNS was_VBD done_VBN by_IN two-color_JJ flow_NN cytometry_NN (_( Epic_NNP XL_NNP
          FL_NNP ,_, Beckman_NNP Coulter_NNP ,_, Allendale_NNP ,_, New_NNP Jersey_NNP ,_, United_NNP States_NNPS )_) using_VBG combinations_NNS of_IN the_DT
          following_VBG monclonal_NN antibodies_NNS :_: FITC-conjugated_NNP anti-_NN CD_NNP 4_CD ,_, -_: CD_NNP 8_CD ,_, and_CC -_: CD_NNP 14_CD ;_: PE-_NNP and_CC
          Cy_NNP 5_CD -_: conjugated_JJ anti-_NN CCR_NNP 4_CD ,_, -_: CCR_NNP 3_CD ,_, -_: CCR_NNP 5_CD ,_, and_CC -_: CXCR_NNP 3_CD ._. Freshly_NNP isolated_VBD lung_NN lymphocytes_NNS
          were_VBD resuspended_JJ to_TO 1_CD ×_NN 10_CD
          7_CD cells_NNS /_NN ml_NN ,_, and_CC 50_CD μl_NN of_IN cells_NNS was_VBD incubated_JJ with_IN antibodies_NNS to_TO CD_NNP 3_CD
          and_CC CD_NNP 4_CD or_CC CD_NNP 8_CD ._.
        
        
          Intracytoplasmic_NNP Cytokine_NNP Staining_NNP
          Lung_NNP lymphocytes_NNS were_VBD cultured_JJ in_IN the_DT presence_NN or_CC absence_NN of_IN phorbol_NN myristate_NN acetate_NN
          (_( PMA_NNP )_) /_NN ionomycin_NN and_CC brefeldin_NN A_DT for_IN 12_CD h_NN ._. Cells_NNP were_VBD harvested_VBN ,_, fixed_VBN with_IN formaldehyde_NN ,_,
          permeabilized_JJ with_IN saponin_NN ,_, and_CC intracellularly_RB labeled_VBN for_IN IFN-γ_NNP and_CC IL-_NNP 4_CD ,_, in_IN addition_NN
          to_TO staining_VBG for_IN surface_NN CD_NNP 69_CD ,_, CD_NNP 4_CD ,_, and_CC CD_NNP 8_CD according_VBG to_TO the_DT manufacturer_NN 's_POS
          recommendations_NNS (_( Fastimmune_NNP ,_, BD_NNP Biosciences_NNP Pharmingen_NNP )_) ._.
        
        
          In_IN Vitro_NNP T_NN Cell_NNP Culture_NNP and_CC Cytokine_NNP Assay_NNP
          Lung_NNP lymphocytes_NNS were_VBD isolated_VBN from_IN surgical_JJ tissue_NN and_CC cultured_JJ in_IN vitro_NN in_IN
          triplicate_NN for_IN 4_CD d_SYM ._. Supernatants_NNP were_VBD collected_VBN and_CC stored_VBN at_IN –_NN 80_CD °_NN C_NNP for_IN future_JJ analysis_NN ._.
          Standard_NNP antibody-based_JJ enzyme-linked_JJ immunosorbent_NN assay_NN was_VBD used_VBN to_TO measure_VB supernatant_NN
          concentrations_NNS of_IN IP-_NNP 10_CD ,_, MIG_NNP ,_, IL-_NNP 4_CD ,_, and_CC IFN-γ_NNP according_VBG to_TO the_DT manufacturer_NN 's_POS
          instructions_NNS (_( R_NN &_CC D_NNP Systems_NNPS and_CC BD_NNP Biosciences_NNP Pharmingen_NNP )_) ._.
        
        
          Detection_NNP of_IN MMP_NNP 12_CD by_IN Western_NNP Blotting_NNP ,_, and_CC Real-_NNP Time_NNP PCR_NNP
          Peripheral_NNP blood_NN mononuclear_NN cells_NNS and_CC lung_NN macrophages_NNS were_VBD isolated_VBN by_IN positive_JJ
          selection_NN using_VBG immunomagnetic_JJ beads_NNS conjugated_JJ with_IN anti-_NN CD_NNP 14_CD ,_, and_CC cultured_JJ in_IN
          serum-free_JJ medium_NN (_( RPMI_NNP ,_, L-_NNP glutamine_NN ,_, and_CC Pen_NNP /_NN Strep_NNP )_) prior_RB to_TO overnight_JJ stimulation_NN with_IN
          0_CD ,_, 50_CD ,_, 250_CD ,_, or_CC 500_CD ng_NN /_NN ml_NN of_IN IFN-γ_NNP ,_, IL-_NNP 4_CD ,_, MIG_NNP ,_, I-TAC_NNP ,_, and_CC IP-_NNP 10_CD ._. Supernatants_NNP were_VBD
          collected_VBN ,_, and_CC MMP_NNP 12_CD was_VBD detected_VBN using_VBG anti-human_JJ MMP_NNP 12_CD (_( R_NN &_CC D_NNP Systems_NNPS )_) by_IN Western_NNP
          blotting_VBG according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._.
          Total_JJ cellular_JJ RNA_NNP was_VBD extracted_VBN from_IN CD_NNP 14_CD
          +_NN lung_NN macrophages_NNS stimulated_VBN overnight_JJ with_IN rIP-_NN 10_CD (_( 500_CD ng_NN /_NN ml_NN )_) in_IN the_DT
          presence_NN or_CC absence_NN of_IN blocking_VBG anti-_NN CXCR_NNP 3_CD antibodies_NNS (_( 5_CD μg_NN /_NN ml_NN ,_, R_NN &_CC D_NNP Systems_NNPS )_) ._.
          Two-step_NNP real-time_JJ reverse_NN transcription_NN PCR_NNP was_VBD used_VBN to_TO determine_VB the_DT relative_JJ
          expression_NN of_IN mRNA_NN using_VBG the_DT ABI_NNP Perkin_NNP Elmer_NNP Prism_NNP 5700_CD Sequence_NNP Detection_NNP System_NNP
          (_( Applied_NNP Biosystems_NNP ,_, Foster_NNP City_NNP ,_, California_NNP ,_, United_NNP States_NNPS )_) as_IN described_VBN previously_RB
          [_NN 38_CD ]_NN ._.
        
        
          Immunostaining_NNP and_CC Histopathology_NNP
          Paraffin-embedded_NNP ,_, and_CC fresh-frozen_JJ lung_NN sections_NNS (_( 5_CD μm_NN )_) were_VBD immunostained_JJ using_VBG
          monoclonal_NN antibodies_NNS against_IN human_JJ MMP_NNP 12_CD (_( R_NN &_CC D_NNP Systems_NNPS )_) or_CC non-immune_JJ antisera_NN by_IN an_DT
          immunoperoxidase_NN protocol_NN (_( Vectastain_NNP Elite_NNP ,_, Vector_NNP Labs_NNPS ,_, Burlingame_NNP ,_, California_NNP ,_, United_NNP
          States_NNPS )_) and_CC counterstained_JJ with_IN hematoxylin_NN as_IN recommended_VBN by_IN the_DT manufacturer_NN ._.
        
        
          Statistical_NNP Analysis_NNP
          The_DT Mann-_NNP Whitney_NNP test_NN (_( non-parametric_JJ ,_, two-tailed_JJ )_) and_CC Student_NNP 's_POS T_NN test_NN (_( two-tailed_JJ )_)
          were_VBD used_VBN to_TO compare_VB differences_NNS between_IN the_DT two_CD groups_NNS of_IN subjects_NNS ._. 
          p_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN statistically_RB significant_JJ ._.
        
      
      
        Results_NNS
        
          Th_NNP 1_CD Immune_NNP Bias_NNP of_IN Peripheral_NNP Lung_NNP Lymphocytes_NNP in_IN Emphysema_NNP
          Inflammatory_NNP chemokines_NNS ,_, cytokines_NNS ,_, and_CC their_PRP$ receptors_NNS are_VBP upregulated_JJ at_IN sites_NNS of_IN
          inflammation_NN and_CC play_VB a_DT key_JJ role_NN in_IN the_DT recruitment_NN of_IN leukocytes_NNS to_TO peripheral_JJ tissues_NNS
          in_IN response_NN to_TO injury_NN [_NN 17_CD ,_, 39_CD ]_NN ._. To_TO detect_VB Th_NNP 1_CD polarization_NN ,_, we_PRP assessed_VBD lung_NN lymphocytes_NNS
          for_IN expression_NN of_IN CCR_NNP 5_CD (_( a_DT receptor_NN for_IN several_JJ Th_NNP 1_CD chemokines_NNS )_) and_CC CXCR_NNP 3_CD (_( the_DT receptor_NN
          for_IN IP-_NNP 10_CD ,_, I-TAC_NNP ,_, and_CC MIG_NNP )_) ._. We_PRP screened_VBD for_IN the_DT presence_NN of_IN Th_NNP 2_CD cells_NNS by_IN assessing_VBG T_NN cell_NN
          expression_NN of_IN CCR_NNP 4_CD —_NN a_DT receptor_NN for_IN eotaxin_NN /_NN CCL_NNP 11_CD ,_, macrophage_NN chemoattractant_NN protein_NN 3_CD
          (_( CCL_NNP 7_CD )_) ,_, and_CC thymus-_NN and_CC activation-regulated_JJ chemokine_NN (_( CCL_NNP 17_CD )_) [_NN 40_CD ,_, 41_CD ]_NN —_NN and_CC CCR_NNP 3_CD ,_, a_DT
          receptor_NN for_IN eotaxin_NN and_CC related_VBN chemokines_NNS ._. Flow_NNP cytometry_NN revealed_VBD very_RB low_JJ expression_NN
          of_IN CCR_NNP 3_CD and_CC CCR_NNP 4_CD (_( 1_CD %_NN –_NN 3_CD %_NN )_) in_IN control_NN (_(
          n_NN =_SYM 10_CD )_) and_CC emphysema_NN (_(
          n_NN =_SYM 18_CD )_) groups_NNS ,_, and_CC did_VBD not_RB discriminate_JJ between_IN these_DT populations_NNS
          (_( Figure_NN 1_CD A_DT and_CC 1_CD B_NNP ;_: data_NNS not_RB shown_VBN )_) ._. These_DT findings_NNS were_VBD in_IN sharp_JJ contrast_NN to_TO the_DT enhanced_JJ
          expression_NN of_IN both_DT CCR_NNP 5_CD and_CC CXCR_NNP 3_CD ,_, as_IN shown_VBN in_IN representative_NN histograms_NNS (_( Figure_NN 1_CD A_DT )_) ._.
          These_DT Th_NNP 1_CD -_: specific_JJ chemokine_NN receptors_NNS were_VBD expressed_VBN prominently_RB on_IN lung_NN lymphocytes_NNS
          from_IN all_DT participants_NNS ,_, but_CC their_PRP$ expression_NN was_VBD significantly_RB enhanced_VBN in_IN the_DT setting_NN of_IN
          emphysema_NN (_( Figure_NN 1_CD A–_NNP 1_CD C_NNP )_) ._. Further_RB ,_, both_DT CD_NNP 4_CD and_CC CD_NNP 8_CD T_NN cells_NNS expressed_VBD CCR_NNP 5_CD at_IN the_DT same_JJ
          level_NN (_( Figure_NN 1_CD C_NNP )_) ._. In_IN contrast_NN ,_, we_PRP found_VBD highly_RB variable_JJ expression_NN (_( 0_CD ._. 5_LS %_NN –_NN 30_CD %_NN )_) of_IN CCR_NNP 4_CD ,_,
          CXCR_NNP 3_CD ,_, and_CC CCR_NNP 5_CD on_IN peripheral_JJ blood_NN lymphocytes_NNS isolated_VBN from_IN the_DT same_JJ participants_NNS ,_, and_CC
          this_DT variation_NN did_VBD not_RB correlate_VBP with_IN the_DT presence_NN of_IN disease_NN in_IN either_DT group_NN (_( data_NNS not_RB
          shown_VBN )_) ._. Furthermore_RB ,_, we_PRP compared_VBD the_DT lung_NN lymphocyte_NN CCR_NNP 5_CD and_CC CXCR_NNP 3_CD profiles_NNS among_IN the_DT
          eight_CD participants_NNS with_IN emphysema_NN alone_RB (_( lung_NN volume_NN reduction_NN surgery_NN for_IN emphysema_NN ;_:
          non-cancer_JJ )_) and_CC ten_CD participants_NNS with_IN emphysema_NN and_CC accompanying_VBG cancer_NN (_( lung_NN resection_NN
          for_IN treatment_NN of_IN small_JJ peripheral_JJ cancer_NN )_) ,_, and_CC found_VBD that_IN these_DT two_CD groups_NNS cannot_NN be_VB
          distinguished_VBN based_VBN on_IN these_DT indices_NNS (_( Figure_NN 1_CD D_NNP ;_: data_NNS not_RB shown_VBN )_) ._.
          Although_IN human_JJ lung_NN macrophages_NNS are_VBP not_RB known_VBN to_TO express_VB CXCR_NNP 3_CD ,_, we_PRP suspected_VBD based_VBN on_IN
          the_DT immunohistochemical_JJ localization_NN of_IN this_DT chemokine_NN receptor_NN that_IN CD_NNP 14_CD
          +_NN cells_NNS in_IN the_DT lungs_NNS of_IN ex-smoker_JJ individuals_NNS with_IN emphysema_NN accounted_VBD
          for_IN much_RB of_IN the_DT total_JJ lung_NN CXCR_NNP 3_CD
          +_NN immunoreactivity_NN (_( Figure_NN 2_CD A_DT ;_: data_NN not_RB shown_VBN )_) ._. To_TO confirm_VB this_DT ,_, we_PRP
          determined_VBD the_DT percent_NN of_IN total_JJ lung_NN cells_NNS expressing_VBG CD_NNP 14_CD and_CC CD_NNP 11_CD b—which_NN are_VBP both_DT
          markers_NNS of_IN monocytes_NNS /_NN macrophages—and_NN CXCR_NNP 3_CD ._. We_PRP found_VBD that_IN over_IN 40_CD %_NN of_IN CD_NNP 14_CD
          +_NN cells_NNS from_IN participants_NNS with_IN emphysema_NN but_CC not_RB control_VB participants_NNS
          were_VBD also_RB positive_JJ for_IN CXCR_NNP 3_CD (_( Figure_NN 2_LS )_) ._. In_IN addition_NN ,_, there_EX was_VBD a_DT significant_JJ negative_JJ
          association_NN between_IN CXCR_NNP 3_CD expression_NN on_IN lung_NN T_NN cells_NNS and_CC the_DT percent_NN of_IN predicted_VBD forced_VBN
          expiratory_NN volume_NN in_IN 1_CD s_VBZ (_( FEV_NNP 1_LS )_) ,_, based_VBN on_IN an_DT 
          R_NN
          2_CD goodness-of-fit_JJ statistic_NN of_IN 0_CD ._. 27_CD (_( Figure_NN 2_CD C_NNP ;_: 
          p_NN =_SYM 0_CD ._. 0089_CD ,_, 
          r_LS =_SYM −_NN 0_CD ._. 52_CD )_) ._. Together_RB ,_, these_DT data_NNS indicate_VBP that_IN a_DT strong_JJ type_NN 1_CD bias_NN is_VBZ
          characteristic_NN of_IN the_DT T_NN cells_NNS isolated_VBN from_IN the_DT peripheral_JJ lung_NN of_IN participants_NNS with_IN COPD_NNP
          and_CC emphysema_NN and_CC that_IN this_DT immune_JJ phenotype_NN correlates_NNS with_IN the_DT lung_NN destruction_NN that_WDT is_VBZ
          characteristic_NN of_IN this_DT disease_NN ._. Further_RB ,_, we_PRP have_VBP shown_VBN for_IN the_DT first_JJ time_NN ,_, to_TO our_PRP$
          knowledge_NN ,_, that_IN CXCR_NNP 3_CD expression_NN ,_, a_DT marker_NN of_IN Th_NNP 1_CD inflammation_NN ,_, extends_VBZ to_TO lung_NN monocytes_NNS
          and_CC macrophages_NNS ._.
        
        
          IFN-γ_NNP ,_, IP-_NNP 10_CD ,_, and_CC MIG_NNP But_CC Not_RB IL-_NNP 4_CD Are_VBP Expressed_NNP by_IN Lung_NNP Lymphocytes_NNP
          We_PRP sought_VBD additional_JJ functional_JJ data_NNS to_TO confirm_VB the_DT apparent_JJ Th_NNP 1_CD bias_NN of_IN peripheral_JJ
          lung_NN inflammatory_JJ cells_NNS isolated_VBN from_IN ex-smoker_JJ individuals_NNS ._. Freshly_NNP isolated_VBD lung_NN
          lymphocytes_NNS that_WDT were_VBD not_RB otherwise_RB manipulated_VBN secreted_JJ high_JJ levels_NNS of_IN IFN-γ_NNP ,_, MIG_NNP ,_, and_CC
          IP-_NNP 10_CD ,_, with_IN significantly_RB greater_JJR secretion_NN of_IN both_DT cytokines_NNS from_IN lymphocytes_NNS of_IN
          participants_NNS with_IN emphysema_NN (_( Figure_NN 3_CD A–_NNP 3_CD C_NNP )_) ._. Interestingly_RB ,_, we_PRP could_MD not_RB detect_VB
          appreciable_JJ amounts_NNS of_IN I-TAC_NNP ,_, another_DT known_VBN ligand_NN for_IN CXCR_NNP 3_CD ,_, in_IN lung_NN lymphocytes_NNS of_IN
          control_NN participants_NNS or_CC those_DT with_IN emphysema_NN (_( data_NNS not_RB shown_VBN )_) ._. Similar_JJ results_NNS were_VBD
          obtained_VBN using_VBG intracytoplasmic_JJ cytokine_NN staining_VBG of_IN the_DT same_JJ cells_NNS (_( Figure_NN 3_CD D_NNP )_) ,_, in_IN which_WDT
          PMA_NNP /_NN ionomycin_NN stimulation_NN strongly_RB induced_VBD IFN-γ_NNP production_NN from_IN CD_NNP 69_CD
          +_NN /_NN CD_NNP 8_CD
          +_NN lung_NN lymphocytes_NNS ._. Surface_NNP staining_VBG for_IN CD_NNP 4_CD was_VBD not_RB feasible_JJ with_IN
          this_DT protocol_NN ;_: however_RB ,_, the_DT percentage_NN of_IN CD_NNP 8_CD
          −_NN /_NN IFN-γ_NNP
          +_NN cells_NNS was_VBD approximately_RB equal_JJ to_TO that_DT of_IN CD_NNP 8_CD
          +_NN /_NN IFN-γ_NNP
          +_NN cells_NNS (_( median_JJ [_NN SD_NNP ]_NN ,_, 19_CD [_NN 6_CD ]_NN versus_CC 16_CD [_NN 4_CD ]_NN ,_, respectively_RB )_) ._. Because_IN total_JJ
          numbers_NNS of_IN CD_NNP 4_CD
          +_NN and_CC CD_NNP 8_CD
          +_NN T_NN cells_NNS were_VBD approximately_RB equivalent_NN ,_, this_DT suggests_VBZ that_DT non-_NN CD_NNP 8_CD
          +_NN /_NN IFN-γ_NNP
          +_NN cells_NNS are_VBP largely_RB CD_NNP 4_CD
          +_NN ,_, and_CC therefore_RB Th_NNP 1_CD cells_NNS ._. Finally_RB ,_, the_DT typical_JJ Th_NNP 2_CD cytokine_NN ,_, IL-_NNP 4_CD ,_,
          was_VBD not_RB detected_VBN in_IN either_DT group_NN ,_, as_IN determined_VBN by_IN enzyme-linked_JJ immunosorbent_NN assay_NN or_CC
          intracytoplasmic_JJ cytokine_NN staining_VBG (_( Figure_NN 3_CD E_NNP ;_: data_NNS not_RB shown_VBN )_) ,_, confirming_VBG the_DT marked_VBD Th_NNP 1_CD
          bias_NN of_IN the_DT immune_JJ response_NN that_WDT underlies_NNS smoking-related_JJ lung_NN inflammation_NN and_CC
          emphysema_NN ._.
        
        
          IP-_NNP 10_CD and_CC MIG_NNP But_CC Not_RB IFN-γ_NNP Directly_NNP Upregulate_NNP MMP_NNP 12_CD through_IN CXCR_NNP 3_CD
          Emphysema_NNP and_CC irreversible_JJ airway_NN limitation_NN that_WDT is_VBZ characteristic_NN of_IN chronic_JJ tobacco_NN
          smoking_NN are_VBP related_VBN to_TO the_DT destruction_NN of_IN elastin_NN and_CC the_DT resulting_VBG loss_NN of_IN lung_NN elastic_JJ
          recoil_NN ._. Therefore_RB ,_, to_TO be_VB relevant_JJ to_TO the_DT pathogenesis_NNS of_IN airway_NN obstruction_NN ,_, type_NN 1_CD
          inflammation_NN must_MD be_VB shown_VBN to_TO promote_VB lung_NN elastolysis_NNS ._. Because_IN loss_NN of_IN elastin_NN is_VBZ
          regulated_VBN by_IN proteinases_NNS [_NN 42_CD ]_NN ,_, we_PRP next_RB determined_VBN if_IN expression_NN of_IN MMPs_NNP ,_, in_IN particular_JJ
          the_DT elastases_NNS MMP_NNP 9_CD and_CC MMP_NNP 12_CD ,_, was_VBD regulated_VBN by_IN IP-_NNP 10_CD ,_, MIG_NNP ,_, and_CC IFN-γ_NNP ,_, the_DT principal_JJ
          cytokines_NNS detected_VBD in_IN emphysematous_JJ lung_NN ._. Indeed_RB ,_, isolated_VBD peripheral_JJ lung_NN macrophages_NNS ,_,
          but_CC not_RB isolated_VBN blood_NN monocytes_NNS ,_, secreted_JJ MMP_NNP 12_CD in_IN response_NN to_TO IP-_NNP 10_CD and_CC MIG_NNP ,_, but_CC not_RB
          IFN-γ_NNP (_( Figure_NN 4_CD A_DT ;_: data_NN not_RB shown_VBN )_) ._. These_DT findings_NNS reflect_VBP a_DT specific_JJ receptor–ligand_NN
          interaction_NN because_IN in_IN the_DT presence_NN of_IN a_DT CXCR_NNP 3_CD function-blocking_JJ antibody_NN ,_, IP-_NNP 10_CD failed_VBD
          to_TO induce_VB MMP_NNP 12_CD (_( Figure_NN 4_CD B_NNP )_) ._. Furthermore_RB ,_, immunohistochemical_JJ studies_NNS revealed_VBD that_IN lung_NN
          macrophages_NNS of_IN participants_NNS with_IN emphysema_NN ,_, but_CC not_RB control_VB participants_NNS ,_, specifically_RB
          express_VB MMP_NNP 12_CD (_( Figure_NN 4_CD C_NNP and_CC 4_CD D_NNP )_) ._. Together_RB ,_, these_DT findings_NNS indicate_VBP that_IN Th_NNP 1_CD ,_, but_CC not_RB
          Th_NNP 2_CD ,_, cytokines_NNS and_CC related_VBN chemokines_NNS are_VBP required_VBN for_IN establishing_VBG the_DT pro-elastolytic_JJ
          lung_NN environment_NN that_WDT underlies_NNS human_JJ emphysema_NN ._.
        
      
      
        Discussion_NNP
        In_IN this_DT investigation_NN ,_, we_PRP characterized_VBD T_NN cells_NNS and_CC lung_NN macrophages_NNS isolated_VBN from_IN
        emphysematous_JJ and_CC non-emphysematous_JJ human_JJ lungs_NNS ._. Three_CD principal_JJ findings_NNS emerge_VBP from_IN our_PRP$
        study_NN ._. First_LS ,_, rather_RB than_IN being_VBG functionally_RB diverse_JJ ,_, as_IN suggested_VBN by_IN the_DT heterogeneous_JJ
        nature_NN of_IN humans_NNS ,_, lung_NN T_NN cells_NNS of_IN ex-smoker_JJ individuals_NNS with_IN emphysema_NN are_VBP relatively_RB
        homogeneous_JJ and_CC characterized_VBN by_IN a_DT marked_VBN Th_NNP 1_CD bias_NN ._. Second_JJ ,_, the_DT principal_JJ Th_NNP 1_CD chemokines_NNS ,_,
        MIG_NNP and_CC IP-_NNP 10_CD ,_, are_VBP linked_VBN to_TO a_DT pro-elastolytic_JJ lung_NN environment_NN because_IN these_DT cytokines_NNS
        upregulate_NN the_DT elastase_NN MMP_NNP 12_CD ,_, which_WDT is_VBZ associated_VBN with_IN emphysema_NN ._. Finally_RB ,_, we_PRP found_VBD no_DT
        significant_JJ expression_NN of_IN Th_NNP 2_CD chemokine_NN receptors_NNS ,_, such_JJ as_IN CCR_NNP 3_CD and_CC CCR_NNP 4_CD ,_, or_CC IL-_NNP 4_CD
        production_NN in_IN lung_NN lymphocytes_NNS ._. Together_RB ,_, our_PRP$ findings_NNS demonstrate_VBP the_DT role_NN of_IN the_DT adaptive_JJ
        immune_JJ response_NN in_IN COPD_NNP and_CC suggest_VBP a_DT primary_JJ role_NN for_IN Th_NNP 1_CD cells_NNS in_IN controlling_VBG the_DT main_JJ
        smoking-related_JJ physiologic_JJ and_CC structural_JJ changes_NNS of_IN the_DT lung_NN ._.
        Upregulation_NNP of_IN CCR_NNP 5_CD and_CC CXCR_NNP 3_CD on_IN T_NN cells_NNS and_CC accumulation_NN of_IN these_DT cells_NNS in_IN the_DT lung_NN
        periphery_NN suggest_VBP that_DT aberrant_NN ,_, unremitting_VBG pulmonary_JJ recruitment_NN of_IN these_DT activated_VBN T_NN
        cells_NNS is_VBZ unique_JJ to_TO people_NNS with_IN smoking-related_JJ lung_NN disease_NN ,_, despite_IN cessation_NN of_IN exposure_NN
        to_TO the_DT inciting_VBG agent_NN ,_, tobacco_NN smoke_NN ._. We_PRP showed_VBD that_IN ex-smoker_JJ individuals_NNS without_IN
        obstructive_JJ lung_NN disease_NN or_CC emphysema_NN have_VBP comparatively_RB little_JJ Th_NNP 1_CD -_: biased_VBN inflammation_NN in_IN
        their_PRP$ lungs_NNS ;_: thus_RB ,_, our_PRP$ findings_NNS reflect_VBP the_DT inflammatory_JJ changes_NNS that_WDT are_VBP unique_JJ to_TO the_DT
        COPD_NNP microenvironment_NN ._. Additionally_RB ,_, lung_NN lymphocytes_NNS isolated_VBN from_IN four_CD lifelong_JJ
        non-smoker_JJ individuals_NNS with_IN severe_JJ obstructive_JJ lung_NN disease_NN due_JJ to_TO cystic_JJ fibrosis_NNS or_CC
        bronchiolitis_NNS obliterans_NNS did_VBD not_RB show_VB a_DT Th_NNP 1_CD inflammatory_JJ bias_NN of_IN the_DT lung_NN (_( S_NNP ._. Grumelli_NNP ,_, F_NN ._.
        Kheradmand_NNP ,_, D_NNP ._. B_NNP ._. Corry_NNP ,_, unpublished_JJ data_NNS )_) ._. This_DT information_NN confirmed_VBD our_PRP$ finding_VBG that_IN the_DT
        predominant_NN Th_NNP 1_CD bias_NN in_IN COPD_NNP /_NN emphysema_NN reflects_VBZ the_DT microenvironment_NN unique_JJ to_TO the_DT lungs_NNS of_IN
        ex-smoker_JJ individuals_NNS ._. The_DT prevalence_NN of_IN asthma_NN among_IN people_NNS who_WP smoke_VBP is_VBZ currently_RB not_RB
        known_VBN ,_, but_CC in_IN order_NN to_TO study_VB COPD_NNP /_NN emphysema_NN in_IN a_DT population_NN without_IN other_JJ confounding_VBG
        variables_NNS ,_, people_NNS who_WP might_MD have_VB had_VBN asthma_NN were_VBD excluded_VBN ,_, and_CC thus_RB our_PRP$ findings_NNS are_VBP
        restricted_VBN to_TO non-asthmatic_JJ individuals_NNS with_IN emphysema_NN ._.
        Our_PRP$ use_NN of_IN T_NN cell_NN chemokine_NN receptor_NN expression_NN analysis_NN to_TO determine_VB recruitment_NN of_IN
        lung_NN T_NN cells_NNS is_VBZ not_RB without_IN precedent_NN ._. Analysis_NNP by_IN immunohistochemistry_NN of_IN airway_NN mucosa_NN of_IN
        people_NNS with_IN atopic_JJ asthma_NN after_IN antigen_NN challenge_NN revealed_VBD that_IN large_JJ numbers_NNS of_IN CCR_NNP 4_CD
        +_NN and_CC CCR_NNP 8_CD
        +_NN T_NN cells_NNS express_VBP IL-_NNP 4_CD ,_, and_CC CCR_NNP 4_CD expression_NN was_VBD prominent_JJ in_IN people_NNS with_IN
        severe_JJ atopic_JJ dermatitis_NNS ,_, which_WDT decreased_VBD upon_IN abatement_NN of_IN disease_NN activity_NN [_NN 26_CD ,_, 43_CD ]_NN ._.
        Immunostaining_NNP of_IN T_NN cells_NNS in_IN synovial_NN fluid_JJ from_IN individuals_NNS with_IN rheumatoid_NN arthritis_NN
        showed_VBD that_IN virtually_RB all_DT of_IN the_DT T_NN cells_NNS associated_VBN with_IN inflamed_JJ joints_NNS expressed_VBD CXCR_NNP 3_CD
        and_CC CCR_NNP 5_CD ,_, representing_VBG significant_JJ enrichment_NN compared_VBN to_TO blood_NN T_NN cells_NNS from_IN the_DT same_JJ
        participants_NNS ._. Furthermore_RB ,_, previous_JJ studies_NNS of_IN smoker_NN individuals_NNS with_IN COPD_NNP and_CC normal_JJ lung_NN
        function_NN showed_VBD the_DT presence_NN of_IN CD_NNP 8_CD
        +_NN /_NN CXCR_NNP 3_CD
        +_NN T_NN cells_NNS in_IN the_DT airway_NN epithelium_NN and_CC submucosa_NN [_NN 44_CD ]_NN ._. We_PRP extend_VBP these_DT
        findings_NNS by_IN showing_VBG CXCR_NNP 3_CD expression_NN on_IN lung_NN macrophages_NNS and_CC CD_NNP 4_CD
        +_NN T_NN cells_NNS in_IN emphysema_NN patients_NNS and_CC the_DT functional_JJ interplay_NN between_IN
        Th_NNP 1_CD -_: related_VBN chemokines_NNS and_CC elastolytic_JJ MMPs_NNP ._.
        In_IN addition_NN to_TO detailing_VBG surface_NN chemokine_NN receptor_NN expression_NN ,_, we_PRP have_VBP functionally_RB
        confirmed_VBN the_DT marked_VBD Th_NNP 1_CD bias_NN of_IN peripheral_JJ lung_NN T_NN cells_NNS ,_, demonstrating_VBG that_IN either_DT at_IN rest_NN
        or_CC following_VBG stimulation_NN ,_, these_DT cells_NNS secrete_NN IFN-γ_NNP and_CC not_RB IL-_NNP 4_CD ._. Our_PRP$ findings_NNS therefore_RB
        confirm_VBP the_DT utility_NN of_IN chemokine_NN receptor_NN expression_NN patterns_NNS in_IN the_DT initial_JJ assessment_NN of_IN
        T_NN cell_NN effector_NN phenotype_NN ._.
        Destruction_NNP of_IN lung_NN parenchyma_NN in_IN emphysema_NN is_VBZ thought_VBN to_TO occur_VB through_IN excessive_JJ
        proteolysis_NNS mediated_JJ by_IN the_DT elastin-degrading_JJ enzymes_NNS MMP_NNP 2_CD ,_, MMP_NNP 9_CD ,_, and_CC MMP_NNP 12_CD from_IN the_DT MMP_NNP
        family_NN ,_, and_CC by_IN neutrophil_NN elastase_NN from_IN the_DT serine_NN proteinase_NN family_NN [_NN 45_CD ,_, 46_CD ]_NN ._. Cytokines_NNP and_CC
        chemokines_NNS are_VBP substrates_NNS for_IN MMPs_NNP ,_, but_CC they_PRP also_RB regulate_VB expression_NN of_IN MMPs_NNP under_IN
        pathological_JJ conditions_NNS [_NN 47_CD ,_, 48_CD ]_NN ._. We_PRP have_VBP shown_VBN here_RB that_IN IP-_NNP 10_CD and_CC MIG_NNP ,_, two_CD chemokines_NNS that_WDT
        are_VBP secreted_JJ from_IN lung_NN lymphocytes_NNS of_IN participants_NNS with_IN emphysema_NN ,_, upregulate_NN specifically_RB
        MMP_NNP 12_CD and_CC thus_RB favor_VB a_DT proteolytic_JJ microenvironment_NN that_IN facilitates_NNS lung_NN destruction_NN ._.
        Strengthening_NNP the_DT association_NN between_IN lung_NN macrophages_NNS and_CC IP-_NNP 10_CD /_NN MIG-dependent_NNP MMP_NNP 12_CD
        secretion_NN is_VBZ the_DT fact_NN that_IN we_PRP have_VBP demonstrated_VBN that_IN in_IN humans_NNS macrophages_NNS ,_, like_IN T_NN cells_NNS ,_,
        express_VB CXCR_NNP 3_CD and_CC that_IN this_DT receptor_NN is_VBZ required_VBN for_IN MMP_NNP 12_CD secretion_NN in_IN response_NN to_TO
        IP-_NNP 10_CD /_NN MIG_NNP stimulation_NN ._. In_IN addition_NN to_TO defining_VBG the_DT predominant_NN immune_JJ phenotype_NN of_IN
        emphysematous_JJ lung_NN ,_, these_DT additional_JJ findings_NNS implicate_VB the_DT principal_JJ cell_NN (_( macrophage_NN )_) ,_,
        MMP_NNP (_( MMP_NNP 12_CD )_) ,_, and_CC effector_NN cytokines_NNS (_( IFN-γ_NNP ,_, IP-_NNP 10_CD ,_, and_CC MIG_NNP )_) as_IN likely_JJ underlying_VBG
        smoking-induced_JJ lung_NN destruction_NN ._. We_PRP have_VBP further_RBR shown_VBN that_IN these_DT enzymes_NNS may_MD be_VB regulated_VBN
        by_IN proximal_NN immune_JJ events_NNS driven_VBN by_IN Th_NNP 1_CD cells_NNS or_CC Th_NNP 1_CD -_: associated_VBN cytokines_NNS ._. A_DT question_NN of_IN
        major_JJ importance_NN for_IN future_JJ study_NN is_VBZ ,_, therefore_RB ,_, the_DT nature_NN of_IN the_DT antigens_NNS and_CC adjuvant_NN
        factors_NNS that_WDT ultimately_RB drive_NN this_DT inflammatory_JJ response_NN ._.
        Although_IN this_DT was_VBD an_DT entirely_RB human_JJ study_NN ,_, our_PRP$ findings_NNS show_VBP remarkable_JJ parallels_NNS with_IN
        studies_NNS performed_VBN in_IN mice_NNS ._. MMP_NNP 12_CD deficiency_NN has_VBZ been_VBN shown_VBN to_TO protect_VB mice_NNS against_IN
        emphysema_NN after_IN chronic_JJ exposure_NN to_TO cigarette_NN smoke_NN ,_, implying_VBG that_IN MMP_NNP 12_CD may_MD be_VB the_DT key_JJ
        proteinase_NN in_IN the_DT development_NN of_IN emphysema_NN in_IN this_DT species_NNS [_NN 49_CD ,_, 50_CD ]_NN ._. Studies_NNS from_IN both_DT
        humans_NNS and_CC mice_NNS therefore_RB firmly_RB suggest_VBP the_DT importance_NN of_IN MMP_NNP 12_CD in_IN the_DT pathogenesis_NNS of_IN
        emphysema_NN ._. Interestingly_RB ,_, in_IN addition_NN to_TO solubilizing_VBG elastin_NN ,_, MMP_NNP 12_CD is_VBZ the_DT MMP_NNP most_RBS
        efficient_JJ at_IN degrading_JJ α_NN 1_CD -_: antitrypsin_NN ,_, the_DT primary_JJ physiological_JJ inhibitor_NN of_IN human_JJ
        leukocyte_NN elastase_NN [_NN 51_CD ,_, 52_CD ]_NN ._. Thus_RB ,_, chemokine-induced_JJ upregulation_NN of_IN MMP_NNP 12_CD may_MD orchestrate_NN
        lung_NN matrix_NN degradation_NN both_DT directly_RB and_CC indirectly_RB through_IN inactivation_NN of_IN
        α_NN 1_CD -_: antitrypsin_NN ._. The_DT therapy_NN of_IN COPD_NNP and_CC emphysema_NN is_VBZ currently_RB limited_VBN to_TO pharmacologic_JJ
        bronchodilation_NN to_TO relieve_VB dyspnea_NN ,_, antibiotics_NNS for_IN intercurrent_NN respiratory_JJ tract_NN
        infection_NN ,_, and_CC vaccination_NN against_IN prominent_JJ respiratory_JJ pathogens_NNS ._. Aside_RB from_IN efforts_NNS to_TO
        prevent_VB smoking_NN or_CC encourage_VB cessation_NN ,_, there_EX exist_VB no_DT measures_NNS that_WDT prevent_VBP development_NN of_IN
        emphysema_NN or_CC treat_VB the_DT specific_JJ causes_NNS of_IN airway_NN obstruction_NN ._. By_IN providing_VBG insight_NN into_IN the_DT
        immunopathogenesis_NNS of_IN COPD_NNP ,_, our_PRP$ findings_NNS provide_VBP genuine_JJ hope_NN that_IN future_JJ therapies_NNS capable_JJ
        of_IN preventing_VBG or_CC halting_VBG smoking-related_JJ lung_NN disease_NN may_MD be_VB possible_JJ ._.
      
    
  
